These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2912300)

  • 41. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
    Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
    Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
    Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
    Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma cholinesterase: gene and variations.
    Pantuck EJ
    Anesth Analg; 1993 Aug; 77(2):380-6. PubMed ID: 8346840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A rare case of silent cholinesterase genetic variant (author's transl)].
    Otte A; Bonilla I; Gil C; Bolinches R; Andreu L; Canós I
    Med Clin (Barc); 1980 Oct; 75(7):309-11. PubMed ID: 7432039
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
    Yang HS; Goudsouzian N; Martyn JA
    Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relation of plasma cholinesterases to response to clinical doses of succinylcholine.
    Kalow W
    Can J Anaesth; 2008 Dec; 55(12):860-68. PubMed ID: 19050090
    [No Abstract]   [Full Text] [Related]  

  • 48. [Mechanism of neuromuscular transmission--relationship between time factor and the development of phase II block induced by succinylcholine chloride].
    Murakami S; Kuze S; Kobayashi T; Hamabe N
    Masui; 1970 Sep; 19(9):937-46. PubMed ID: 5466639
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine.
    Lockridge O
    Pharmacol Ther; 1990; 47(1):35-60. PubMed ID: 2195556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between the level of cholinesterase in plasma and the action of suxamethonium in animals.
    Hobbiger F; Peck AW
    Br J Pharmacol; 1970 Dec; 40(4):775-89. PubMed ID: 4322043
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Plasma cholinesterase activity in transverse paralysis].
    Neumann HW; Dippold A
    Zentralbl Chir; 1971 Jun; 96(25):833-7. PubMed ID: 5130906
    [No Abstract]   [Full Text] [Related]  

  • 52. Heterozygotes for atypical cholinesterase.
    Owen H; Hunter AR
    Br J Anaesth; 1983 Apr; 55(4):315-8. PubMed ID: 6838745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients.
    Goldberg ME; Larijani GE; Azad SS; Sosis M; Seltzer JL; Ascher J; Weakly JN
    Anesth Analg; 1989 Jul; 69(1):93-9. PubMed ID: 2525886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
    Frampton JE; McTavish D
    Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade.
    Naguib M; el-Gammal M; Daoud W; Ammar A; Moukhtar H; Turkistani A
    Anesthesiology; 1995 May; 82(5):1288-92. PubMed ID: 7741305
    [No Abstract]   [Full Text] [Related]  

  • 56. [Diltiazem potentiation of neuromuscular blockage produced by pancuronium or succinylcholine].
    Hashimoto Y; Irimada T; Teshigawara T; Koga Y; Iwatsuki N
    Masui; 1986 Nov; 35(11):1689-93. PubMed ID: 3029451
    [No Abstract]   [Full Text] [Related]  

  • 57. Inheritance of low plasma cholinesterase activity in two families with a history of suxamethonium sensitivity.
    Whittaker M; Berry M; Britten JJ
    Anaesthesia; 1989 Jun; 44(6):480-2. PubMed ID: 2757153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma cholinesterase activity in bank blood.
    Epstein HM; Jarzemsky D; Zuckerman L; Vagher P
    Anesth Analg; 1980 Mar; 59(3):211-4. PubMed ID: 7189352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuromuscular blockade in a patient with active dermatomyositis.
    Brown S; Shupak RC; Patel C; Calkins JM
    Anesthesiology; 1992 Nov; 77(5):1031-3. PubMed ID: 1443721
    [No Abstract]   [Full Text] [Related]  

  • 60. Relative importance of the enzymic hydrolysis of sexamethonium in plasma and tissues: studies in Rhesus monkeys.
    Peck AW
    Br J Pharmacol; 1972 May; 45(1):64-70. PubMed ID: 4625272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.